Cadrenal Therapeutics Inc (CVKD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CVKD Annual Balance Sheets →
From Cadrenal Therapeutics Inc through Dec 31 2024, shifts in Jun 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Dec 31 2024)
Assets
Cash & cash equivalent2.39
Cash, Cash Equivalents Other2.09
Cash & Short-term Investments4.00
Interest Receivable, Current0.01
Deferred Costs, Current AS0.10
Other Current Assets0.60
Prepaid Expense And Other Assets Current0.41
Total Current Assets5.58
Equipment/Property/Plant Net0.00
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Operating Lease Right Of Use Asset-
Total Assets5.59
Liabilities
Accounts Payable, Current AC0.87
Accrued Liabilities, Current AC0.63
Other Liabilities, Current0.00
Total Current Liabilities1.50
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current-
Total Liabilities1.50
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock48.87
Retained Earnings / Accumulated Deficit-44.78
Other Equity0.00
Common Stockholder's Equity4.09
Total Stockholder's Equity4.09
Liabilities & Stockholder's Equity5.59
4 historic quarters locked

Sign in to unlock the full Cadrenal Therapeutics Inc balance sheet history.

About Cadrenal Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-089153

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.